With our Q4 and full year 2024 financial results in, we’re proud to report strong global growth. Our dedication to addressing the underserved market of those affected by Afib and post-op pain continues to drive us forward. We’re gearing up for another impactful year ahead.

Discover the full earnings report at: <a href="https://okt.to/GT2z3I&quot; target="_blank">https://okt.to/GT2z3I</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=Earnings&highlightedUpd…; target='_blank'>#Earnings</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=FinancialResults&highli…; target='_blank'>#FinancialResults</a>